Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type Of Synthesis (Biotech, Synthetic), By Type Of Manufacturer (Captive, Merchant), By Type, By Application, By Type Of Drug, By Region, And Segment Forecast to 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation
                        1.1.1. Market Definitions
                    1.2. Objectives
                        1.2.1. OBJECTIVE - 1
                        1.2.2. OBJECTIVE - 2
                        1.2.3. OBJECTIVE - 3
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. PURCHASED DATABASE
                        1.4.2. GVR’S INTERNAL DATABASE
                        1.4.3. SECONDARY SOURCES
                        1.4.4. PRIMARY RESEARCH
                    1.5. Information or Data Analysis
                        1.5.1. DATA ANALYSIS MODELS
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. COMMODITY FLOW ANALYSIS
                    1.8. List of Secondary Sources
                    1.9. List of Abbreviations
                    1.10. List of Primary Sources
Chapter 2. Executive Summary
                    2.1. Market Snapshot
                    2.2. Segment Snapshot
                    2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Segmentation and Scope
                    3.2. Market Lineage Outlook
                        3.2.1. Parent Market Outlook
                        3.2.2. Related/Ancillary Market Outlook
                    3.3. Market Dynamics
                    3.4. Market Drivers
                        3.4.1. Increasing geriatric population
                        3.4.2. Rising prevalence of target diseases such as hospital-acquired infections, genetic, cardiovascular, and neurological diseases
                        3.4.3. Increasing preference for targeted therapy approach in cancer treatment
                        3.4.4. Increasing preference for outsourcing APIs
                    3.5. Market Restraint Analysis
                        3.5.1. High capital investments and production cost
                        3.5.2. Stringent Safety and handling regulations regarding APIs
                    3.6. Business Environment Analysis
                        3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
                        3.6.2. Porter’s Five Forces Analysis
                        3.6.3. COVID-19 Impact Analysis
                    3.7. Global Sales of API Molecules , USD Million, 2019-2023
                        3.7.1. Granisetron
                        3.7.2. Leflunomide
                        3.7.3. Mometasone
                        3.7.4. Ondansetron
                        3.7.5. Pazopanib
                        3.7.6. Pantoprazole
                        3.7.7. Pirfenidone
                        3.7.8. Praziquantel
                        3.7.9. Levocetirizine
                        3.7.10. Budesonide
                        3.7.11. Famcyclovir
                        3.7.12. Dutasteride
                        3.7.13. Sacubitiril Valsatran
                        3.7.14. Nintedanib
                        3.7.15. Olaparib
                        3.7.16. Ruxolitinib
                        3.7.17. Imatinib
                        3.7.18. Sorafenib
                        3.7.19. Abiraterone
                        3.7.20. Pomalidomide
                        3.7.21. Dasatanib
                        3.7.22. Relugolix
                        3.7.23. Niraparib
                        3.7.24. Efinaconazole
                        3.7.25. Linagliptin
                        3.7.26. Rivaroxaban
                        3.7.27. Tacrolimus
                        3.7.28. Vortioxetine
                        3.7.29. Mirabegron
                    3.8. Key Companies of API Molecules
                        3.8.1. Granisetron
                        3.8.2. Leflunomide
                        3.8.3. Mometasone
                        3.8.4. Ondansetron
                        3.8.5. Pazopanib
                        3.8.6. Pantoprazole
                        3.8.7. Pirfenidone
                        3.8.8. Praziquantel
                        3.8.9. Levocetirizine
                        3.8.10. Budesonide
                        3.8.11. Famcyclovir
                        3.8.12. Dutasteride
                        3.8.13. Sacubitiril Valsatran
                        3.8.14. Nintedanib
                        3.8.15. Olaparib
                        3.8.16. Ruxolitinib
                        3.8.17. Imatinib
                        3.8.18. Sorafenib
                        3.8.19. Abiraterone
                        3.8.20. Pomalidomide
                        3.8.21. Dasatanib
                        3.8.22. Relugolix
                        3.8.23. Niraparib
                        3.8.24. Efinaconazole
                        3.8.25. Linagliptin
                        3.8.26. Rivaroxaban
                        3.8.27. Tacrolimus
                        3.8.28. Vortioxetine
                        3.8.29. Mirabegron
Chapter 4. Type of Synthesis Business Analysis
                    4.1. Active Pharmaceutical Ingredients Market: Type of Synthesis Movement Analysis
                    4.2. Biotic APIs
                        4.2.1. Biotic APIs Market, 2018 - 2030 (USD Billion)
                            4.2.1.1. Biotech APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
                            4.2.1.2. Generic APIs
                                4.2.1.2.1. Generic APIs Market, 2018 - 2030 (USD Billion)
                            4.2.1.3. Innovative APIs
                                4.2.1.3.1. Innovative APIs Market, 2018 - 2030 (USD Billion)
                            4.2.1.4. Biotech APIs Market, By Product (Revenue, USD Billion, 2018 - 2030)
                            4.2.1.5. Monoclonal Antibodies
                                4.2.1.5.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Billion)
                            4.2.1.6. Hormones
                                4.2.1.6.1. Hormones Market, 2018 - 2030 (USD Billion)
                            4.2.1.7. Cytokines
                                4.2.1.7.1. Cytokines Market, 2018 - 2030 (USD Billion)
                            4.2.1.8. Recombinant Proteins
                                4.2.1.8.1. Recombinant Proteins Market, 2018 - 2030 (USD Billion)
                            4.2.1.9. Therapeutic Enzymes
                                4.2.1.9.1. Therapeutic Enzymes Market, 2018 - 2030 (USD Billion)
                            4.2.1.10. Vaccines
                                4.2.1.10.1. Vaccines Market, 2018 - 2030 (USD Billion)
                            4.2.1.11. Blood Factors
                                4.2.1.11.1. Blood Factors Market, 2018 - 2030 (USD Billion)
                    4.3. Synthetic APIs
                        4.3.1. Synthetic APIs Market, 2018 - 2030 (USD Billion)
                            4.3.1.1. Synthetic APIs Market, By Type (Revenue, USD Billion, 2018 - 2030)
                            4.3.1.2. Generic APIs
                                4.3.1.2.1. Generic APIs Market, 2018 - 2030 (USD Billion)
                            4.3.1.3. Innovative APIs
                                4.3.1.3.1. Innovative APIs Market, 2018 - 2030 (USD Billion)
Chapter 5. Type of Manufacturer Business Analysis
                    5.1. Active Pharmaceutical Ingredients Market: Type of Manufacturer Movement Analysis
                    5.2. Captive APIs
                        5.2.1. Captive APIs Market, 2018 - 2030 (USD Billion)
                    5.3. Merchant APIs
                        5.3.1. Merchant APIs Market, 2018 - 2030 (USD Billion)
Chapter 6. Type Business Analysis
                    6.1. Active Pharmaceutical Ingredients Market: Type Movement Analysis
                    6.2. Generic APIs
                        6.2.1. Generic APIs Market, 2018 - 2030 (USD Billion)
                    6.3. Innovative APIs
                        6.3.1. Innovative APIs Market, 2018 - 2030 (USD Billion)
Chapter 7. Application Business Analysis
                    7.1. Active Pharmaceutical Ingredients Market: Application Movement Analysis
                    7.2. Cardiovascular Diseases
                        7.2.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Billion)
                    7.3. Oncology
                        7.3.1. Innovative APIs Oncology Market, 2018 - 2030 (USD Billion)
                    7.4. CNS and Neurology
                        7.4.1. CNS and Neurology Market, 2018 - 2030 (USD Billion)
                    7.5. Orthopedic
                        7.5.1. Orthopedic Market, 2018 - 2030 (USD Billion)
                    7.6. Endocrinology
                        7.6.1. Endocrinology Market, 2018 - 2030 (USD Billion)
                    7.7. Pulmonology
                        7.7.1. Pulmonology Market, 2018 - 2030 (USD Billion)
                    7.8. Gastroenterology
                        7.8.1. Gastroenterology Market, 2018 - 2030 (USD Billion)
                    7.9. Nephrology
                        7.9.1. Nephrology Market, 2018 - 2030 (USD Billion)
                    7.10. Ophthalmology
                        7.10.1. Ophthalmology Market, 2018 - 2030 (USD Billion)
                    7.11. Others
                        7.11.1. Others Market, 2018 - 2030 (USD Billion)
Chapter 8. Type of Drug Business Analysis
                    8.1. Active Pharmaceutical Ingredients Market: Type of Drug Movement Analysis
                    8.2. Prescription
                        8.2.1. Prescription Market, 2018 - 2030 (USD Billion)
                    8.3. OTC
                        8.3.1. OTC Market, 2018 - 2030 (USD Billion)
Chapter 9. Regional Business Analysis
                    9.1. Active Pharmaceutical Ingredients Market Share By Region, 2023 & 2030
                    9.2. North America
                        9.2.1. North America Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.2.2. U.S.
                            9.2.2.1. Key Country Dynamics
                            9.2.2.2. Target Disease Prevalence
                            9.2.2.3. Competitive Scenario
                            9.2.2.4. Regulatory Framework
                            9.2.2.5. Reimbursement Scenario
                            9.2.2.6. U.S. Active pharmaceutical ingredients market, 2018 - 2030 (USD MILLION)
                        9.2.3. Canada
                            9.2.3.1. Key Country Dynamics
                            9.2.3.2. Target Disease Prevalence
                            9.2.3.3. Competitive Scenario
                            9.2.3.4. Regulatory Framework
                            9.2.3.5. Reimbursement Scenario
                            9.2.3.6. Canada Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                    9.3. Europe
                        9.3.1. Europe Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.3.2. Germany
                            9.3.2.1. Key Country Dynamics
                            9.3.2.2. Target Disease Prevalence
                            9.3.2.3. Competitive Scenario
                            9.3.2.4. Regulatory Framework
                            9.3.2.5. Reimbursement Scenario
                            9.3.2.6. Germany Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.3.3. UK
                            9.3.3.1. Key Country Dynamics
                            9.3.3.2. Target Disease Prevalence
                            9.3.3.3. Competitive Scenario
                            9.3.3.4. Regulatory Framework
                            9.3.3.5. Reimbursement Scenario
                            9.3.3.6. UK Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.3.4. France
                            9.3.4.1. Key Country Dynamics
                            9.3.4.2. Target Disease Prevalence
                            9.3.4.3. Competitive Scenario
                            9.3.4.4. Regulatory Framework
                            9.3.4.5. Reimbursement Scenario
                            9.3.4.6. France Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.3.5. Italy
                            9.3.5.1. Key Country Dynamics
                            9.3.5.2. Target Disease Prevalence
                            9.3.5.3. Competitive Scenario
                            9.3.5.4. Regulatory Framework
                            9.3.5.5. Reimbursement Scenario
                            9.3.5.6. Italy Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.3.6. Spain
                            9.3.6.1. Key Country Dynamics
                            9.3.6.2. Target Disease Prevalence
                            9.3.6.3. Competitive Scenario
                            9.3.6.4. Regulatory Framework
                            9.3.6.5. Reimbursement Scenario
                            9.3.6.6. Spain Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.3.7. Denmark
                            9.3.7.1. Key Country Dynamics
                            9.3.7.2. Target Disease Prevalence
                            9.3.7.3. Competitive Scenario
                            9.3.7.4. Regulatory Framework
                            9.3.7.5. Reimbursement Scenario
                            9.3.7.6. Denmark Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.3.8. Sweden
                            9.3.8.1. Key Country Dynamics
                            9.3.8.2. Target Disease Prevalence
                            9.3.8.3. Competitive Scenario
                            9.3.8.4. Regulatory Framework
                            9.3.8.5. Reimbursement Scenario
                            9.3.8.6. Sweden Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.3.9. Norway
                            9.3.9.1. Key Country Dynamics
                            9.3.9.2. Target Disease Prevalence
                            9.3.9.3. Competitive Scenario
                            9.3.9.4. Regulatory Framework
                            9.3.9.5. Reimbursement Scenario
                            9.3.9.6. Norway Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.3.10. Russia
                            9.3.10.1. Key Country Dynamics
                            9.3.10.2. Target Disease Prevalence
                            9.3.10.3. Competitive Scenario
                            9.3.10.4. Regulatory Framework
                            9.3.10.5. Reimbursement Scenario
                            9.3.10.6. France Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.3.11. Hungary
                            9.3.11.1. Key Country Dynamics
                            9.3.11.2. Target Disease Prevalence
                            9.3.11.3. Competitive Scenario
                            9.3.11.4. Regulatory Framework
                            9.3.11.5. Reimbursement Scenario
                            9.3.11.6. Italy Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.3.12. Poland
                            9.3.12.1. Key Country Dynamics
                            9.3.12.2. Target Disease Prevalence
                            9.3.12.3. Competitive Scenario
                            9.3.12.4. Regulatory Framework
                            9.3.12.5. Reimbursement Scenario
                            9.3.12.6. Spain Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.3.13. Switzerland
                            9.3.13.1. Key Country Dynamics
                            9.3.13.2. Target Disease Prevalence
                            9.3.13.3. Competitive Scenario
                            9.3.13.4. Regulatory Framework
                            9.3.13.5. Reimbursement Scenario
                            9.3.13.6. Switzerland Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.3.14. Portugal
                            9.3.14.1. Key Country Dynamics
                            9.3.14.2. Target Disease Prevalence
                            9.3.14.3. Competitive Scenario
                            9.3.14.4. Regulatory Framework
                            9.3.14.5. Reimbursement Scenario
                            9.3.14.6. Portugal Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.3.15. Greece
                            9.3.15.1. Key Country Dynamics
                            9.3.15.2. Target Disease Prevalence
                            9.3.15.3. Competitive Scenario
                            9.3.15.4. Regulatory Framework
                            9.3.15.5. Reimbursement Scenario
                            9.3.15.6. Greece Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                    9.4. Asia Pacific
                        9.4.1. Asia Pacific Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.4.2. Japan
                            9.4.2.1. Key Country Dynamics
                            9.4.2.2. Target Disease Prevalence
                            9.4.2.3. Competitive Scenario
                            9.4.2.4. Regulatory Framework
                            9.4.2.5. Reimbursement Scenario
                            9.4.2.6. Japan Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.4.3. China
                            9.4.3.1. Key Country Dynamics
                            9.4.3.2. Target Disease Prevalence
                            9.4.3.3. Competitive Scenario
                            9.4.3.4. Regulatory Framework
                            9.4.3.5. Reimbursement Scenario
                            9.4.3.6. China Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.4.4. India
                            9.4.4.1. Key Country Dynamics
                            9.4.4.2. Target Disease Prevalence
                            9.4.4.3. Competitive Scenario
                            9.4.4.4. Regulatory Framework
                            9.4.4.5. Reimbursement Scenario
                            9.4.4.6. India Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.4.5. South Korea
                            9.4.5.1. Key Country Dynamics
                            9.4.5.2. Target Disease Prevalence
                            9.4.5.3. Competitive Scenario
                            9.4.5.4. Regulatory Framework
                            9.4.5.5. Reimbursement Scenario
                            9.4.5.6. South Korea Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.4.6. Australia
                            9.4.6.1. Key Country Dynamics
                            9.4.6.2. Target Disease Prevalence
                            9.4.6.3. Competitive Scenario
                            9.4.6.4. Regulatory Framework
                            9.4.6.5. Reimbursement Scenario
                            9.4.6.6. Australia Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.4.7. Thailand
                            9.4.7.1. Key Country Dynamics
                            9.4.7.2. Target Disease Prevalence
                            9.4.7.3. Competitive Scenario
                            9.4.7.4. Regulatory Framework
                            9.4.7.5. Reimbursement Scenario
                            9.4.7.6. Thailand Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.4.8. Vietnam
                            9.4.8.1. Key Country Dynamics
                            9.4.8.2. Target Disease Prevalence
                            9.4.8.3. Competitive Scenario
                            9.4.8.4. Regulatory Framework
                            9.4.8.5. Reimbursement Scenario
                            9.4.8.6. Vietnam Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.4.9. Indonesia
                            9.4.9.1. Key Country Dynamics
                            9.4.9.2. Target Disease Prevalence
                            9.4.9.3. Competitive Scenario
                            9.4.9.4. Regulatory Framework
                            9.4.9.5. Reimbursement Scenario
                            9.4.9.6. Indonesia Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.4.10. Malaysia
                            9.4.10.1. Key Country Dynamics
                            9.4.10.2. Target Disease Prevalence
                            9.4.10.3. Competitive Scenario
                            9.4.10.4. Regulatory Framework
                            9.4.10.5. Reimbursement Scenario
                            9.4.10.6. Malaysia Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.4.11. Taiwan
                            9.4.11.1. Key Country Dynamics
                            9.4.11.2. Target Disease Prevalence
                            9.4.11.3. Competitive Scenario
                            9.4.11.4. Regulatory Framework
                            9.4.11.5. Reimbursement Scenario
                            9.4.11.6. Taiwan Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.4.12. Philippines
                            9.4.12.1. Key Country Dynamics
                            9.4.12.2. Target Disease Prevalence
                            9.4.12.3. Competitive Scenario
                            9.4.12.4. Regulatory Framework
                            9.4.12.5. Reimbursement Scenario
                            9.4.12.6. Philippines Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                    9.5. Latin America
                        9.5.1. Latin America Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.5.2. Brazil
                            9.5.2.1. Key Country Dynamics
                            9.5.2.2. Target Disease Prevalence
                            9.5.2.3. Competitive Scenario
                            9.5.2.4. Regulatory Framework
                            9.5.2.5. Reimbursement Scenario
                            9.5.2.6. Brazil Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.5.3. Mexico
                            9.5.3.1. Key Country Dynamics
                            9.5.3.2. Target Disease Prevalence
                            9.5.3.3. Competitive Scenario
                            9.5.3.4. Regulatory Framework
                            9.5.3.5. Reimbursement Scenario
                            9.5.3.6. Mexico Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.5.4. Argentina
                            9.5.4.1. Key Country Dynamics
                            9.5.4.2. Target Disease Prevalence
                            9.5.4.3. Competitive Scenario
                            9.5.4.4. Regulatory Framework
                            9.5.4.5. Reimbursement Scenario
                            9.5.4.6. Argentina Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.5.5. Columbia
                            9.5.5.1. Key Country Dynamics
                            9.5.5.2. Target Disease Prevalence
                            9.5.5.3. Competitive Scenario
                            9.5.5.4. Regulatory Framework
                            9.5.5.5. Reimbursement Scenario
                            9.5.5.6. Columbia Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.5.6. Peru
                            9.5.6.1. Key Country Dynamics
                            9.5.6.2. Target Disease Prevalence
                            9.5.6.3. Competitive Scenario
                            9.5.6.4. Regulatory Framework
                            9.5.6.5. Reimbursement Scenario
                            9.5.6.6. Peru Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.5.7. Chile
                            9.5.7.1. Key Country Dynamics
                            9.5.7.2. Target Disease Prevalence
                            9.5.7.3. Competitive Scenario
                            9.5.7.4. Regulatory Framework
                            9.5.7.5. Reimbursement Scenario
                            9.5.7.6. Chile Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                    9.6. MEA
                        9.6.1. MEA Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.6.2. South Africa
                            9.6.2.1. Key Country Dynamics
                            9.6.2.2. Target Disease Prevalence
                            9.6.2.3. Competitive Scenario
                            9.6.2.4. Regulatory Framework
                            9.6.2.5. Reimbursement Scenario
                            9.6.2.6. South Africa Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.6.3. Saudi Arabia
                            9.6.3.1. Key Country Dynamics
                            9.6.3.2. Target Disease Prevalence
                            9.6.3.3. Competitive Scenario
                            9.6.3.4. Regulatory Framework
                            9.6.3.5. Reimbursement Scenario
                            9.6.3.6. Saudi Arabia Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.6.4. UAE
                            9.6.4.1. Key Country Dynamics
                            9.6.4.2. Target Disease Prevalence
                            9.6.4.3. Competitive Scenario
                            9.6.4.4. Regulatory Framework
                            9.6.4.5. Reimbursement Scenario
                            9.6.4.6. UAE Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.6.5. Kuwait
                            9.6.5.1. Key Country Dynamics
                            9.6.5.2. Target Disease Prevalence
                            9.6.5.3. Competitive Scenario
                            9.6.5.4. Regulatory Framework
                            9.6.5.5. Reimbursement Scenario
                            9.6.5.6. Kuwait Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.6.6. Egypt
                            9.6.6.1. Key Country Dynamics
                            9.6.6.2. Target Disease Prevalence
                            9.6.6.3. Competitive Scenario
                            9.6.6.4. Regulatory Framework
                            9.6.6.5. Reimbursement Scenario
                            9.6.6.6. Egypt Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.6.7. Israel
                            9.6.7.1. Key Country Dynamics
                            9.6.7.2. Target Disease Prevalence
                            9.6.7.3. Competitive Scenario
                            9.6.7.4. Regulatory Framework
                            9.6.7.5. Reimbursement Scenario
                            9.6.7.6. Israel Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.6.8. Belarus
                            9.6.8.1. Key Country Dynamics
                            9.6.8.2. Target Disease Prevalence
                            9.6.8.3. Competitive Scenario
                            9.6.8.4. Regulatory Framework
                            9.6.8.5. Reimbursement Scenario
                            9.6.8.6. Belarus Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.6.9. Algeria
                            9.6.9.1. Key Country Dynamics
                            9.6.9.2. Target Disease Prevalence
                            9.6.9.3. Competitive Scenario
                            9.6.9.4. Regulatory Framework
                            9.6.9.5. Reimbursement Scenario
                            9.6.9.6. Algeria Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.6.10. Jordan
                            9.6.10.1. Key Country Dynamics
                            9.6.10.2. Target Disease Prevalence
                            9.6.10.3. Competitive Scenario
                            9.6.10.4. Regulatory Framework
                            9.6.10.5. Reimbursement Scenario
                            9.6.10.6. Jordan Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
                        9.6.11. Iran
                            9.6.11.1. Key Country Dynamics
                            9.6.11.2. Target Disease Prevalence
                            9.6.11.3. Competitive Scenario
                            9.6.11.4. Regulatory Framework
                            9.6.11.5. Reimbursement Scenario
                            9.6.11.6. Iran Active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Chapter 10. Competitive Landscape
                    10.1. Participant’s overview
                    10.2. Financial performance
                    10.3. Participant categorization
                        10.3.1. Market Leaders
                        10.3.2. Active Pharmaceutical Ingredients Market Share Analysis, 2023
                        10.3.3. Company Profiles
                            10.3.3.1. Dr. Reddy’s Laboratories Ltd.
                                10.3.3.1.1. Company Overview
                                10.3.3.1.2. Financial Performance
                                10.3.3.1.3. Product Benchmarking
                                10.3.3.1.4. Strategic Initiatives
                            10.3.3.2. Sun Pharmaceutical Industries Ltd.
                                10.3.3.2.1. Company Overview
                                10.3.3.2.2. Financial Performance
                                10.3.3.2.3. Product Benchmarking
                                10.3.3.2.4. Strategic Initiatives
                            10.3.3.3. Teva Pharmaceutical Industries Ltd.
                                10.3.3.3.1. Company Overview
                                10.3.3.3.2. Financial Performance
                                10.3.3.3.3. Product Benchmarking
                                10.3.3.3.4. Strategic Initiatives
                            10.3.3.4. Cipla Inc.
                                10.3.3.4.1. Company Overview
                                10.3.3.4.2. Financial Performance
                                10.3.3.4.3. Product Benchmarking
                                10.3.3.4.4. Strategic Initiatives
                            10.3.3.5. AbbVie Inc.
                                10.3.3.5.1. Company Overview
                                10.3.3.5.2. Financial Performance
                                10.3.3.5.3. Product Benchmarking
                                10.3.3.5.4. Strategic Initiatives
                            10.3.3.6. Aurobindo Pharma
                                10.3.3.6.1. Company Overview
                                10.3.3.6.2. Financial Performance
                                10.3.3.6.3. Product Benchmarking
                                10.3.3.6.4. Strategic Initiatives
                            10.3.3.7. Sandoz International GmbH (Novartis AG)
                                10.3.3.7.1. Company Overview
                                10.3.3.7.2. Financial Performance
                                10.3.3.7.3. Product Benchmarking
                                10.3.3.7.4. Strategic Initiatives
                            10.3.3.8. Viatris Inc.
                                10.3.3.8.1. Company Overview
                                10.3.3.8.2. Financial Performance
                                10.3.3.8.3. Product Benchmarking
                                10.3.3.8.4. Strategic Initiatives
                            10.3.3.9. Fresenius Kabi AG
                                10.3.3.9.1. Company Overview
                                10.3.3.9.2. Financial Performance
                                10.3.3.9.3. Product Benchmarking
                                10.3.3.9.4. Strategic Initiatives
                            10.3.3.10. STADA Arzneimittel AG
                                10.3.3.10.1. Company Overview
                                10.3.3.10.2. Financial Performance
                                10.3.3.10.3. Product Benchmarking
                                10.3.3.10.4. Strategic Initiatives
                        10.3.4. Strategy Mapping
                            10.3.4.1. Expansion
                            10.3.4.2. Acquisition
                            10.3.4.3. Collaborations
                            10.3.4.4. Disease Type/Drug Class Launch
                            10.3.4.5. Partnerships
                            10.3.4.6. Others
Chapter 11. Conclusion

List of Tables

Table 1 Global Active Pharmaceutical Ingredients Market, By Region, 2018 - 2030 (USD Billion)
Table 2 Global Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 3 Global Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 4 Global Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 5 Global Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 6 Global Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 7 North America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
Table 8 North America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 9 North America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 10 North America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 11 North America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 12 North America Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 13 U.S. Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 14 U.S. Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 15 U.S. Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 16 U.S. Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 17 U.S. Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 18 Canada Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 19 Canada Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 20 Canada Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 21 Canada Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 22 Canada Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 23 Europe Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
Table 24 Europe Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 25 Europe Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 26 Europe Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 27 Europe Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 28 Europe Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 29 UK Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 30 UK Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 31 UK Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 32 UK Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 33 UK Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 34 Germany Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 35 Germany Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 36 Germany Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 37 Germany Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 38 Germany Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 39 France Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 40 France Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 41 France Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 42 France Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 43 France Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 44 Italy Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 45 Italy Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 46 Italy Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 47 Italy Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 48 Italy Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 49 Spain Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 50 Spain Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 51 Spain Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 52 Spain Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 53 Spain Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 54 Denmark Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 55 Denmark Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 56 Denmark Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 57 Denmark Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 58 Denmark Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 59 Sweden Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 60 Sweden Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 61 Sweden Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 62 Sweden Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 63 Sweden Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 64 Norway Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 65 Norway Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 66 Norway Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 67 Norway Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 68 Norway Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 69 Russia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 70 Russia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 71 Russia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 72 Russia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 73 Russia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 74 Hungary Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 75 Hungary Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 76 Hungary Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 77 Hungary Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 78 Hungary Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 79 Poland Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 80 Poland Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 81 Poland Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 82 Poland Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 83 Poland Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 84 Switzerland Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 85 Switzerland Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 86 Switzerland Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 87 Switzerland Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 88 Switzerland Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 89 Portugal Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 90 Portugal Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 91 Portugal Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 92 Portugal Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 93 Portugal Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 94 Greece Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 95 Greece Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 96 Greece Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 97 Greece Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 98 Greece Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 99 Asia Pacific Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
Table 100 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 101 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 102 Asia Pacific Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 103 Asia Pacific Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 104 Asia Pacific Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 105 Japan Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 106 Japan Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 107 Japan Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 108 Japan Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 109 Japan Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 110 China Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 111 China Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 112 China Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 113 China Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 114 China Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 115 India Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 116 India Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 117 India Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 118 India Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 119 India Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 120 Australia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 121 Australia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 122 Australia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 123 Australia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 124 Australia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 125 South Korea Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 126 South Korea Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 127 South Korea Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 128 South Korea Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 129 South Korea Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 130 Thailand Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 131 Thailand Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 132 Thailand Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 133 Thailand Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 134 Thailand Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 135 Vietnam Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 136 Vietnam Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 137 Vietnam Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 138 Vietnam Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 139 Vietnam Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 140 Indonesia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 141 Indonesia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 142 Indonesia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 143 Indonesia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 144 Indonesia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 145 Malaysia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 146 Malaysia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 147 Malaysia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 148 Malaysia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 149 Malaysia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 150 Taiwan Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 151 Taiwan Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 152 Taiwan Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 153 Taiwan Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 154 Taiwan Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 155 Philippines Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 156 Philippines Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 157 Philippines Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 158 Philippines Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 159 Philippines Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 160 Latin America Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
Table 161 Latin America Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 162 Latin America Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 163 Latin America Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 164 Latin America Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 165 Latin America Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 166 Brazil Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 167 Brazil Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 168 Brazil Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 169 Brazil Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 170 Brazil Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 171 Mexico Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 172 Mexico Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 173 Mexico Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 174 Mexico Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 175 Mexico Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 176 Argentina Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 177 Argentina Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 178 Argentina Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 179 Argentina Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 180 Argentina Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 181 Columbia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 182 Columbia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 183 Columbia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 184 Columbia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 185 Columbia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 186 Peru Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 187 Peru Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 188 Peru Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 189 Peru Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 190 Peru Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 191 Chile Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 192 Chile Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 193 Chile Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 194 Chile Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 195 Chile Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 196 Middle East & Africa Active Pharmaceutical Ingredients Market, By Country, 2018 - 2030 (USD Billion)
Table 197 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 198 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 199 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 200 Middle East & Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 201 Middle East & Africa Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 202 South Africa Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 203 South Africa Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 204 South Africa Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 205 South Africa Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 206 South Africa Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 207 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 208 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 209 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 210 Saudi Arabia Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 211 Saudi Arabia Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 212 UAE Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 213 UAE Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 214 UAE Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 215 UAE Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 216 UAE Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 217 Kuwait Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 218 Kuwait Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 219 Kuwait Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 220 Kuwait Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 221 Kuwait Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 222 Egypt Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 223 Egypt Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 224 Egypt Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 225 Egypt Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 226 Egypt Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 227 Israel Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 228 Israel Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 229 Israel Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 230 Israel Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 231 Israel Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 232 Belarus Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 233 Belarus Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 234 Belarus Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 235 Belarus Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 236 Belarus Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 237 Algeria Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 238 Algeria Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 239 Algeria Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 240 Algeria Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 241 Algeria Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 242 Jordan Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 243 Jordan Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 244 Jordan Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 245 Jordan Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 246 Jordan Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)
Table 247 Iran Active Pharmaceutical Ingredients Market, By Type of Synthesis, 2018 - 2030 (USD Billion)
Table 248 Iran Active Pharmaceutical Ingredients Market, By Type of Manufacturer, 2018 - 2030 (USD Billion)
Table 249 Iran Active Pharmaceutical Ingredients Market, By Type, 2018 - 2030 (USD Billion)
Table 250 Iran Active Pharmaceutical Ingredients Market, By Application, 2018 - 2030 (USD Billion)
Table 251 Iran Active Pharmaceutical Ingredients Market, By Type of Drug, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Active pharmaceutical ingredients market segmentation
Fig. 8 Market driver relevance analysis (Current & future impact)
Fig. 9 Market restraint relevance analysis (Current & future impact)
Fig. 10 Market challenge relevance analysis (Current & future impact)
Fig. 11 Penetration & growth prospect mapping
Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 Market penetration vs growth prospect mapping
Fig. 15 Active pharmaceutical ingredients market: Type of synthesis movement analysis
Fig. 16 Biotech APIs market, 2018 - 2030 (USD Billion)
Fig. 17 Synthetic APIs market, 2018 - 2030 (USD Billion)
Fig. 18 Active pharmaceutical ingredients market: Type of manufacturer movement analysis
Fig. 19 Captive APIs market, 2018 - 2030 (USD Billion)
Fig. 20 Merchant APIs market, 2018 - 2030 (USD Billion)
Fig. 21 Active pharmaceutical ingredients market: Type movement analysis
Fig. 22 Generic APIs market, 2018 - 2030 (USD Billion)
Fig. 23 Innovative APIs market, 2018 - 2030 (USD Billion)
Fig. 24 Active pharmaceutical ingredients market: Application movement analysis
Fig. 25 Cardiovascular diseases market, 2018 - 2030 (USD Billion)
Fig. 26 Oncology market, 2018 - 2030 (USD Billion)
Fig. 27 CNS and Neurology market, 2018 - 2030 (USD Billion)
Fig. 28 Orthopaedic market, 2018 - 2030 (USD Billion)
Fig. 29 Endocrinology market, 2018 - 2030 (USD Billion)
Fig. 30 Pulmonology market, 2018 - 2030 (USD Billion)
Fig. 31 Gastroenterology market, 2018 - 2030 (USD Billion)
Fig. 32 Nephrology market, 2018 - 2030 (USD Billion)
Fig. 33 Ophthalmology market, 2018 - 2030 (USD Billion)
Fig. 34 Others market, 2018 - 2030 (USD Billion)
Fig. 35 Active pharmaceutical ingredients market: Type of drug movement analysis
Fig. 36 Prescription market, 2018 - 2030 (USD Billion)
Fig. 37 OTC market, 2018 - 2030 (USD Billion)
Fig. 38 Regional marketplace: Key takeaways
Fig. 39 Regional outlook, 2018 & 2030
Fig. 40 North America active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 41 U.S. active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 42 Canada active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 43 Europe active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 44 UK active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 45 Germany active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 46 Italy active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 47 Spain active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 48 France active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 49 Denmark active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 50 Sweden active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 51 Norway active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 52 Russia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 53 Hungary active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 54 Poland active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 55 Switzerland active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 56 Portugal active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 57 Greece active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 58 Asia Pacific active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 59 Japan active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 60 China active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 61 India active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 62 Australia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 63 South Korea active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 64 Thailand active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 65 Vietnam active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 66 Indonesia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 67 Malaysia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 68 Taiwan active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 69 Philippines active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 70 Latin America active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 71 Brazil active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 72 Mexico active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 73 Argentina active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 74 Columbia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 75 Peru active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 76 Chile active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 77 MEA active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 78 South Africa active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 79 Saudi Arabia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 80 UAE active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 81 Kuwait active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 82 Egypt active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 83 Israel active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 84 Belarus Arabia active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 85 Algeria active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 86 Jordan active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)
Fig. 87 Iran active pharmaceutical ingredients market, 2018 - 2030 (USD Billion)